However, Li et al. showed that LAG-3 attenuates the effector function of CD8 T-cells in HCC, which contributes to tumor progression as it has been established that higher levels of CD8 T-cells are associated with greater anti-tumor effects and therefore better prognosis [167]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.